These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1351792)

  • 1. Reversal of vinblastine resistance by a new staurosporine derivative, NA-382, in P388/ADR cells.
    Miyamoto K; Wakusawa S; Inoko K; Takagi K; Koyama M
    Cancer Lett; 1992 Jun; 64(2):177-83. PubMed ID: 1351792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of multidrug resistance by a new staurosporine derivative, NA-382, in vitro and in vivo.
    Miyamoto K; Inoko K; Wakusawa S; Kajita S; Hasegawa T; Takagi K; Koyama M
    Cancer Res; 1993 Apr; 53(7):1555-9. PubMed ID: 8095855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of staurosporine derivatives on protein kinase activity and vinblastine accumulation in mouse leukaemia P388/ADR cells.
    Miyamoto K; Inoko K; Ikeda K; Wakusawa S; Kajita S; Hasegawa T; Takagi K; Koyama M
    J Pharm Pharmacol; 1993 Jan; 45(1):43-7. PubMed ID: 8094445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Saturable function of P-glycoprotein as a drug-efflux pump in multidrug-resistant tumour cells.
    Miyamoto KI; Koga-Takeda K; Koga K; Ohshima T; Nomura M
    J Pharm Pharmacol; 1996 May; 48(5):522-5. PubMed ID: 8799879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of isoquinolinesulphonamide compounds on multidrug-resistant P388 cells.
    Nakamura S; Wakusawa S; Tajima K; Miyamoto K; Hagiwara M; Hidaka H
    J Pharm Pharmacol; 1993 Apr; 45(4):268-73. PubMed ID: 8098366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumour effects and pharmacokinetics of combination of vinblastine with a staurosporine derivative, NA-382, in P388/ADR-bearing mice.
    Miyamoto K; Takeda K; Koga K; Ohshima T; Wakusawa S
    J Pharm Pharmacol; 1995 Jun; 47(6):524-9. PubMed ID: 7674138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of P-glycoprotein-dependent resistance to vinblastine by newly synthesized bisbenzylisoquinoline alkaloids in mouse leukemia P388 cells.
    Wang FP; Wang L; Yang JS; Nomura M; Miyamoto K
    Biol Pharm Bull; 2005 Oct; 28(10):1979-82. PubMed ID: 16204959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circumvention of multidrug resistance in P388 murine leukemia cells by a novel inhibitor of cyclic AMP-dependent protein kinase, H-87.
    Miyamoto K; Wakusawa S; Nakamura S; Koshiura R; Otsuka K; Naito K; Hagiwara M; Hidaka H
    Cancer Lett; 1990 May; 51(1):37-42. PubMed ID: 2337896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The protein kinase C inhibitor CGP 41251, a staurosporine derivative with antitumor activity, reverses multidrug resistance.
    Utz I; Hofer S; Regenass U; Hilbe W; Thaler J; Grunicke H; Hofmann J
    Int J Cancer; 1994 Apr; 57(1):104-10. PubMed ID: 7908658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a new triazinoaminopiperidine derivative on adriamycin accumulation and retention in cells displaying P-glycoprotein-mediated multidrug resistance.
    Léonce S; Pierré A; Anstett M; Pérez V; Genton A; Bizzari JP; Atassi G
    Biochem Pharmacol; 1992 Nov; 44(9):1707-15. PubMed ID: 1360210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of staurosporine and four analogues: their effects on growth, rhodamine 123 retention and binding to P-glycoprotein in multidrug-resistant MCF-7/Adr cells.
    Budworth J; Davies R; Malkhandi J; Gant TW; Ferry DR; Gescher A
    Br J Cancer; 1996 May; 73(9):1063-8. PubMed ID: 8624264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal by two dihydropyridine compounds of resistance to multiple anticancer agents in mouse P388 leukemia in vivo and in vitro.
    Kiue A; Sano T; Naito A; Inada H; Suzuki K; Okumura M; Kikuchi J; Sato S; Takano H; Kohno K
    Jpn J Cancer Res; 1990 Oct; 81(10):1057-64. PubMed ID: 1977728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obviation of drug resistance and affinity purification of P-glycoprotein by isoquinolinesulfonamides.
    Hagiwara M; Wakusawa S; Miyamoto K; Hidaka H
    Cancer Lett; 1991 Nov; 60(2):103-7. PubMed ID: 1682033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azidopine noncompetitively interacts with vinblastine and cyclosporin A binding to P-glycoprotein in multidrug resistant cells.
    Tamai I; Safa AR
    J Biol Chem; 1991 Sep; 266(25):16796-800. PubMed ID: 1679434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staurosporine derivatives reverse multidrug resistance without correlation with their protein kinase inhibitory activities.
    Wakusawa S; Inoko K; Miyamoto K; Kajita S; Hasegawa T; Harimaya K; Koyama M
    J Antibiot (Tokyo); 1993 Feb; 46(2):353-5. PubMed ID: 8096836
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of Calphostin C (PKC inhibitor) on daunorubicin resistance in P388/ADR and HL60/AR cells: reversal of drug resistance possibly via P-glycoprotein.
    Gupta S; Patel K; Singh H; Gollapudi S
    Cancer Lett; 1994 Jan; 76(2-3):139-45. PubMed ID: 7511983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staurosporine, a potent inhibitor of C-kinase, enhances drug accumulation in multidrug-resistant cells.
    Sato W; Yusa K; Naito M; Tsuruo T
    Biochem Biophys Res Commun; 1990 Dec; 173(3):1252-7. PubMed ID: 1980066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agents which reverse multidrug-resistance are inhibitors of [3H]vinblastine transport by isolated vesicles.
    Horio M; Lovelace E; Pastan I; Gottesman MM
    Biochim Biophys Acta; 1991 Jan; 1061(1):106-10. PubMed ID: 1671642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of vinblastine resistance in human leukemic cells by haloperidol and dihydrohaloperidol.
    Kataoka Y; Ishikawa M; Miura M; Takeshita M; Fujita R; Furusawa S; Takayanagi M; Takayanagi Y; Sasaki K
    Biol Pharm Bull; 2001 Jun; 24(6):612-7. PubMed ID: 11411546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of tamoxifen on the multidrug-resistant phenotype in human breast cancer cells: isobologram, drug accumulation, and M(r) 170,000 glycoprotein (gp170) binding studies.
    Leonessa F; Jacobson M; Boyle B; Lippman J; McGarvey M; Clarke R
    Cancer Res; 1994 Jan; 54(2):441-7. PubMed ID: 7903910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.